GlassScriptPhysician profile
Tyler A Lee
NPI 1093256539
$3,836.93
in general payments reported to CMS, 2019-2025
15 companies · $1,142 in 2025
The $1,142 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.53 · 2020: $18.10 · 2021: $332 · 2022: $569 · 2023: $843 · 2024: $857 · 2025: $1,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,824 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,824.06 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $702.97 | 2021-2025 | Cequa |
| Bausch & Lomb Americas INC. | $571.72 | 2022-2025 | Xiidra, Infuse, Miebo |
| Johnson & Johnson Vision Care, INC. | $571.17 | 2021-2025 | Acuvue |
| Oyster Point Pharma, INC. | $508.34 | 2022-2024 | Tyrvaya |
| Alcon Vision LLC | $414.22 | 2021-2025 | Precision7, Total30 |
| Tarsus Pharmaceuticals, INC. | $238.39 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $204.68 | 2022-2025 | Oxervate |
| Allergan, INC. | $169.36 | 2019-2022 | |
| Biotissue Holdings INC. | $155.26 | 2023-2025 | |
| Coopervision INC. | $118.77 | 2021-2025 | Myday Contact Lens |
| Novartis Pharmaceuticals Corporation | $108.32 | 2022-2023 | |
| Genzyme Corporation | $29.19 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.10 | 2020 | |
| Kala Pharmaceuticals, INC. | $14.46 | 2021 | |
| Sight Sciences, INC. | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.